Morning Market Movers

Alnylam Pharmaceuticals

rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck

. Genzyme and Alnylam expanded their collaboration on rare genetic diseases. Rexahn Pharmaceuticals

jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period. Rosetta Genomics

moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company. Teche Holding Company

shares jumped 28.44% to $70.00 after IBERIABANK

announced an agreement to acquire Teche Holding.